There is provided an isolated antibody that binds to VEGF-A and neutralizes VEGF-A activity, said antibody comprising a VL domain comprising CDRs LCDR1, LCDR2 and LCDR3, and a VH domain comprising CDRs HCDR1, HCDR2 and HCDR3, wherein:LCDR1 has the amino acid sequence shown in SEQ ID NO: 448;LCDR2 has the amino acid sequence shown in SEQ ID NO: 449;LCDR3 has the amino acid sequence shown in SEQ ID NO: 450;HCDR1 has the amino acid sequence shown in SEQ ID NO: 451;HCDR2 has the amino acid sequence shown in SEQ ID NO: 452;HCDR3 has an amino acid sequence selected from the group consisting of SEQ ID NOs: 453-461.